99
Participants
Start Date
July 31, 2015
Primary Completion Date
June 30, 2021
Study Completion Date
June 30, 2021
Degarelix (GnRH antagonist)
Day-1: Blood samples will be obtained every 10 minutes for 10 hours. After 10 hours of blood samples have been collected, the GnRH antagonist degarelix will be given subcutaneously.
recombinant FSH
Day-2: Blood samples will again be obtained every 10 minutes for 10 hours. Repeated boluses of exogenous recombinant FSH (rFSH) will be given by IV during this 10 hour visit.
Cetrorelix
Day-1: Blood samples will be obtained every 10 minutes for 10 hours. After 10 hours of blood samples have been collected, the GnRH antagonist Cetrorelix will be given subcutaneously.
University of Colorado Clinical and Translational Research Center, Aurora
National Center for Advancing Translational Sciences (NCATS)
NIH
University of Colorado, Denver
OTHER